Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 62

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase

Haghighi, Kobra, Pritchard, Tracy, Bossuyt, Julie, Waggoner, Jason R., Yuan, Qunying, Fan, Guo-Chang, Osinska, Hanna, Anjak, Ahmad, Rubinstein, Jack, Robbins, Jeffrey, Bers, Donald M., Kranias, Evangelia G. · 2012 · Journal of Molecular and Cellular Cardiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.yjmcc.2011.11.012

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 43

  1. Cohn, 1997, Current concepts in the treatment of congestive heart failure, Cardiology, 88, 2, 10.1159/000177477 · DOI
  2. Brini, 2009, Calcium pumps in health and disease, Physiol Rev, 89, 1341, 10.1152/physrev.00032.2008 · DOI · Paper page
  3. Bers, 2008, Calcium cycling and signaling in cardiac myocytes, Annu Rev Physiol, 70, 23, 10.1146/annurev.physiol.70.113006.100455 · DOI · Paper page
  4. MacLennan, 2003, Phospholamban: a crucial regulator of cardiac contractility, Nat Rev Mol Cell Biol, 4, 566, 10.1038/nrm1151 · DOI · Paper page
  5. Brittsan, 2000, Phospholamban and cardiac contractile function, J Mol Cell Cardiol, 32, 2131, 10.1006/jmcc.2000.1270 · DOI · Paper page
  6. Ke, 2008, Regulation of cardiac excitation and contraction by p21 activated kinase-1, Prog Biophys Mol Biol, 98, 238, 10.1016/j.pbiomolbio.2009.01.007 · DOI
  7. Koss, 1996, Phospholamban: a prominent regulator of myocardial contractility, Circ Res, 79, 1059, 10.1161/01.RES.79.6.1059 · DOI · Paper page
  8. Simmerman, 1998, Phospholamban: protein structure, mechanism of action, and role in cardiac function, Physiol Rev, 78, 921, 10.1152/physrev.1998.78.4.921 · DOI · Paper page
  9. Brittsan, 2003, Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport, Circ Res, 92, 769, 10.1161/01.RES.0000066661.49920.59 · DOI
  10. Tada, 1983, Effects of phospholamban phosphorylation catalyzed by adenosine 3′:5′-monophosphate and calmodulin-dependent protein kinases on calcium transport ATPase of cardiac sarcoplasmic reticulum, J Mol Cell Cardiol, 15, 335, 10.1016/0022-2828(83)91345-7 · doi:10.1016/0022-2828(83)91345-7
  11. Kranias, 1985, Regulation of Ca2+ transport by cyclic 3′,5′-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum, Biochim Biophys Acta, 844, 193, 10.1016/0167-4889(85)90090-4 · DOI
  12. Luo, 1996, Phospholamban gene dosage effects in the mammalian heart, Circ Res, 78, 839, 10.1161/01.RES.78.5.839 · DOI
  13. Kadambi, 1996, Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice, J Clin Invest, 97, 533, 10.1172/JCI118446 · DOI · Paper page
  14. Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc Natl Acad Sci U S A, 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
  15. Posch, 2009, Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes, Heart Rhythm, 6, 480, 10.1016/j.hrthm.2009.01.016 · DOI
  16. Chu, 2000, A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta-agonists, J Biol Chem, 275, 38938, 10.1074/jbc.M004079200 · DOI · Paper page
  17. Brittsan, 2000, Maximal inhibition of SERCA2 Ca2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban, J Biol Chem, 275, 12129, 10.1074/jbc.275.16.12129 · DOI
  18. Luo, 1994, Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation, Circ Res, 75, 401, 10.1161/01.RES.75.3.401 · DOI · Paper page
  19. Zhao, 2006, The presence of Lys27 instead of Asn27 in human phospholamban promotes sarcoplasmic reticulum Ca2+-ATPase superinhibition and cardiac remodeling, Circulation, 113, 995, 10.1161/CIRCULATIONAHA.105.583351 · DOI
  20. Krenz, 2007, Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart, J Biol Chem, 282, 24057, 10.1074/jbc.M704574200 · DOI
  21. Pritchard, 2007, Transgenic mice expressing Na+-K+-ATPase in smooth muscle decreases blood pressure, Am J Physiol Heart Circ Physiol, 293, H1172, 10.1152/ajpheart.00279.2007 · DOI
  22. Bossuyt, 2009, Isoform specificity of the Na/K-ATPase association and regulation by phospholemman, J Biol Chem, 284, 26749, 10.1074/jbc.M109.047357 · DOI
  23. Robia, 2007, Förster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex, Circ Res, 101, 1123, 10.1161/CIRCRESAHA.107.159947 · DOI
  24. Despa, 2005, Phospholemman-phosphorylation mediates the ß-adrenergic effects on Na/K pump function in cardiac myocytes, Circ Res, 97, 252, 10.1161/01.RES.0000176532.97731.e5 · DOI · Paper page
  25. Rubinstein, 2009, Hypercholesterolemia and myocardial function evaluated via tissue Doppler imaging, Cardiovasc Ultrasound, 7, 56, 10.1186/1476-7120-7-56 · DOI
  26. Chu, 1998, Phospholamban ablation and compensatory responses in the mammalian heart, Ann N Y Acad Sci, 853, 49, 10.1111/j.1749-6632.1998.tb08256.x · DOI
  27. Menick, 2007, Regulation of Ncx1 gene expression in the normal and hypertrophic heart, Ann N Y Acad Sci, 1099, 195, 10.1196/annals.1387.058 · DOI
  28. Xu, 2005, The role of p38 in the regulation of Na+-Ca2+ exchanger expression in adult cardiomyocytes, J Mol Cell Cardiol, 38, 735, 10.1016/j.yjmcc.2005.03.002 · DOI
  29. Eijssen, 2008, Altered myocardial gene expression reveals possible maladaptive processes in heterozygous and homozygous cardiac myosin-binding protein C knockout mice, Genomics, 91, 52, 10.1016/j.ygeno.2007.09.005 · doi:10.1016/j.ygeno.2007.09.005
  30. Wang, 2007, Mitogen-activated protein kinases in heart development and diseases, Circulation, 116, 1413, 10.1161/CIRCULATIONAHA.106.679589 · DOI · Paper page
  31. Sharma, 2010, Endoplasmic reticulum protein targeting of phospholamban: a common role for an N-terminal di-arginine motif in ER retention, PLoS One, 5, e11496, 10.1371/journal.pone.0011496 · DOI
  32. Stenoien, 2007, Cellular trafficking of phospholamban and formation of functional sarcoplasmic reticulum during myocyte differentiation, Am J Physiol Cell Physiol, 292, C2084, 10.1152/ajpcell.00523.2006 · DOI
  33. Clayton, 2005, The cytoplasmic domains of phospholamban and phospholemman associate with phospholipid membrane surfaces, Biochemistry, 44, 17016, 10.1021/bi0511383 · doi:10.1021/bi0511383
  34. Shattock, 2009, Phospholemman: its role in normal cardiac physiology and potential as a druggable target in disease, Curr Opin Pharmacol, 9, 160, 10.1016/j.coph.2008.12.015 · DOI
  35. Sweadner, 2001, Structural similarities of Na, K-ATPase and SERCA, the Ca2+-ATPase of the sarcoplasmic reticulum, Biochem J, 356, 685, 10.1042/0264-6021:3560685 · doi:10.1042/0264-6021:3560685 · Paper page
  36. Zhang, 2008, Na+/K+-ATPase -mediated signal transduction and Na+/K+-ATPase regulation, Fundam Clin Pharmacol, 22, 615, 10.1111/j.1472-8206.2008.00620.x · DOI
  37. Aperia, 2007, New roles for an old enzyme: Na, K-ATPase emerges as an interesting drug target, J Intern Med, 261, 44, 10.1111/j.1365-2796.2006.01745.x · DOI · Paper page
  38. Xie, 2002, Na+/K+-ATPase as a signal transducer, Eur J Biochem, 269, 2434, 10.1046/j.1432-1033.2002.02910.x · DOI · Paper page
  39. Gan, 2010, Sodium–hydrogen exchange inhibition attenuates glycoside-induced hypertrophy in rat ventricular myocytes, Cardiovasc Res, 85, 79, 10.1093/cvr/cvp283 · doi:10.1093/cvr/cvp283
  40. Kometiani, 2000, Regulation of Na/K-ATPase b1-subunit gene expression by ouabain and other hypertrophic stimuli in neonatal rat cardiac myocytes, Mol Cell Biochem, 215, 65, 10.1023/A:1026503319387 · DOI
  41. Dmitrieva, 2002, Cardiotonic steroids: potential endogenous sodium pump ligands with diverse function, Exp Biol Med, 227, 561, 10.1177/153537020222700803 · DOI
  42. Tian, 2008, The Na-K-ATPase and calcium-signaling microdomains, Physiology, 23, 205, 10.1152/physiol.00008.2008 · DOI
  43. Pierre, 2007, Ouabain triggers preconditioning through activation of the Na+K+-ATPase signaling cascade in rat hearts, Cardiovasc Res, 73, 488, 10.1016/j.cardiores.2006.11.003 · DOI

Cited by

See all 62

Metadata

Authors
Haghighi, K., Pritchard, T., Bossuyt, J., Waggoner, J. R., Yuan, Q., Fan, G.-C., Osinska, H., Anjak, A., Rubinstein, J., Robbins, J., Bers, D. M., & Kranias, E. G.
Venue
Journal of Molecular and Cellular Cardiology
Publisher
Elsevier BV
Published
2012-03
Volume
52
Issue
3
Pages
773-782
ISSN
0022-2828
Cited by
62
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • National Institutes of Health (HL-77101, HL-026057, HL-64018, HL-81562)
  • Leducq Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.